AbbVie Inc.
BG ˙ BUL ˙ US00287Y1091
SecurityBG:4AB / AbbVie Inc.
InstitutionBerkeley Capital Partners, LLC
Latest Disclosed Ownership7,702 shares
Latest Disclosed Value $ 1,675,114
Berkeley Capital Partners, LLC reports 1.56% decrease in ownership of 4AB / AbbVie Inc.

On May 6, 2026 - Berkeley Capital Partners, LLC filed a 13F-HR form disclosing ownership of 7,702 shares of AbbVie Inc. (BG:4AB) valued at $1,675,114 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 5, 2026 disclosing 7,824 shares of AbbVie Inc.. This represents a change in shares of -1.56% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-06 2026-03-31 13F ABBVIE COM 00287Y109 7,702 -122 -1.56 1,675 -6.27 0.3884
2026-02-05 2025-12-31 13F ABBVIE COM 00287Y109 7,824 -175 -2.19 1,788 -3.51 0.4210
2025-11-10 2025-09-30 13F ABBVIE COM 00287Y109 7,999 -62 -0.77 1,852 23.80 0.4380
2025-07-30 2025-06-30 13F ABBVIE COM 00287Y109 8,061 42 0.52 1,496 -10.95 0.3794
2025-05-05 2025-03-31 13F ABBVIE COM 00287Y109 8,019 166 2.11 1,680 20.43 0.4620
2025-02-11 2024-12-31 13F ABBVIE COM 00287Y109 7,853 -124 -1.55 1,396 -11.43 0.3879
2024-11-14 2024-09-30 13F ABBVIE COM 00287Y109 7,977 773 10.73 1,575 27.53 0.4498
2024-08-14 2024-06-30 13F ABBVIE COM 00287Y109 7,204 -18 -0.25 1,236 -6.08 0.3721
2024-05-14 2024-03-31 13F ABBVIE COM 00287Y109 7,222 -193 -2.60 1,315 14.45 0.4010
2024-02-09 2023-12-31 13F ABBVIE COM 00287Y109 7,415 -136 -1.80 1,149 2.13 0.3800
2023-11-14 2023-09-30 13F ABBVIE COM 00287Y109 7,551 57 0.76 1,126 11.50 0.4064
2023-08-03 2023-06-30 13F ABBVIE COM 00287Y109 7,494 30 0.40 1,010 -15.14 0.3576
2023-05-02 2023-03-31 13F ABBVIE COM 00287Y109 7,464 278 3.87 1,190 2.41 0.4408
2023-02-10 2022-12-31 13F ABBVIE COM 00287Y109 7,186 -196 -2.66 1,161 17.15 0.4492
2022-11-04 2022-09-30 13F ABBVIE COM 00287Y109 7,382 24 0.33 991 -12.07 0.4288
2022-08-04 2022-06-30 13F ABBVIE COM 00287Y109 7,358 25 0.34 1,127 -5.21 0.4649
2022-05-05 2022-03-31 13F ABBVIE COM 00287Y109 7,333 931 14.54 1,189 37.14 0.4738
2022-02-14 2021-12-31 13F ABBVIE COM 00287Y109 6,402 -186 -2.82 867 21.94 0.3561
2021-11-04 2021-09-30 13F ABBVIE COM 00287Y109 6,588 -102 -1.52 711 -5.70 0.3274
2021-08-16 2021-06-30 13F ABBVIE COM 00287Y109 6,690 52 0.78 754 5.01 0.3358
2021-05-04 2021-03-31 13F ABBVIE COM 00287Y109 6,638 289 4.55 718 5.59 0.3463
2021-01-28 2020-12-31 13F ABBVIE COM 00287Y109 6,349 12 0.19 680 22.52 0.3491
2020-11-03 2020-09-30 13F ABBVIE COM 00287Y109 6,337 238 3.90 555 -7.35 0.3387
2020-07-30 2020-06-30 13F ABBVIE COM 00287Y109 6,099 195 3.30 599 33.11 0.3690
2020-04-21 2020-03-31 13F ABBVIE COM 00287Y109 5,904 324 5.81 450 -8.91 0.3057
2020-01-24 2019-12-31 13F ABBVIE COM 00287Y109 5,580 -1,505 -21.24 494 -7.84 0.2530
2019-11-01 2019-09-30 13F ABBVIE COM 00287Y109 7,085 -1,095 -13.39 536 -9.92 0.2828
2019-08-08 2019-06-30 13F AbbVie COM 00287Y109 8,180 2,423 42.09 595 28.23 0.2775
2019-04-30 2019-03-31 13F AbbVie COM 00287Y109 5,757 1,056 22.46 464 7.16 0.2295
2019-01-28 2018-12-31 13F AbbVie COM 00287Y109 4,701 4,701 433 0.2410
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.